These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35114152)

  • 1. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
    Raje NS; Anaissie E; Kumar SK; Lonial S; Martin T; Gertz MA; Krishnan A; Hari P; Ludwig H; O'Donnell E; Yee A; Kaufman JL; Cohen AD; Garderet L; Wechalekar AF; Terpos E; Khatry N; Niesvizky R; Yi Q; Joshua DE; Saikia T; Leung N; Engelhardt M; Mothy M; Branagan A; Chari A; Reiman AJ; Lipe B; Richter J; Rajkumar SV; Miguel JS; Anderson KC; Stadtmauer EA; Prabhala RH; McCarthy PL; Munshi NC
    Lancet Haematol; 2022 Feb; 9(2):e143-e161. PubMed ID: 35114152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma.
    Teh BW; Reynolds G; Slavin MA; Cooley L; Roberts M; Liu E; Thursky K; Talaulikar D; Mollee P; Szabo F; Ward C; Chan H; Prince HM; Harrison SJ;
    Intern Med J; 2023 Aug; 53(8):1469-1477. PubMed ID: 37093163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations.
    Girmenia C; Cavo M; Offidani M; Scaglione F; Corso A; Di Raimondo F; Musto P; Petrucci MT; Barosi G
    Blood Rev; 2019 Mar; 34():84-94. PubMed ID: 30683446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network.
    Ludwig H; Sonneveld P; Facon T; San-Miguel J; Avet-Loiseau H; Mohty M; Mateos MV; Moreau P; Cavo M; Pawlyn C; Zweegman S; Engelhardt M; Driessen C; Cook G; Dimopoulos MA; Gay F; Einsele H; Delforge M; Caers J; Weisel K; Jackson G; Garderet L; van de Donk N; Leleu X; Goldschmidt H; Beksac M; Nijhof I; Schreder M; Abildgaard N; Hajek R; Zojer N; Kastritis E; Broijl A; Schjesvold F; Boccadoro M; Terpos E
    Lancet Haematol; 2021 Dec; 8(12):e934-e946. PubMed ID: 34756169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
    Raje N; Anderson K; Einsele H; Efebera Y; Gay F; Hammond SP; Lesokhin AM; Lonial S; Ludwig H; Moreau P; Patel K; Ramasamy K; Mateos MV
    Blood Cancer J; 2023 Aug; 13(1):116. PubMed ID: 37528088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
    Terpos E; Morgan G; Dimopoulos MA; Drake MT; Lentzsch S; Raje N; Sezer O; García-Sanz R; Shimizu K; Turesson I; Reiman T; Jurczyszyn A; Merlini G; Spencer A; Leleu X; Cavo M; Munshi N; Rajkumar SV; Durie BG; Roodman GD
    J Clin Oncol; 2013 Jun; 31(18):2347-57. PubMed ID: 23690408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.
    Ludwig H; Boccadoro M; Moreau P; San-Miguel J; Cavo M; Pawlyn C; Zweegman S; Facon T; Driessen C; Hajek R; Dimopoulos MA; Gay F; Avet-Loiseau H; Terpos E; Zojer N; Mohty M; Mateos MV; Einsele H; Delforge M; Caers J; Weisel K; Jackson G; Garderet L; Engelhardt M; van de Donk N; Leleu X; Goldschmidt H; Beksac M; Nijhof I; Abildgaard N; Bringhen S; Sonneveld P
    Leukemia; 2021 Jan; 35(1):31-44. PubMed ID: 32814840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of infections including vaccination strategies in multiple myeloma.
    Ludwig H; Kumar S
    Am J Hematol; 2023 Mar; 98 Suppl 2():S46-S62. PubMed ID: 36251367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelosuppression associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.
    Miceli T; Colson K; Gavino M; Lilleby K;
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):13-20. PubMed ID: 18490253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious complications in a course of multiple myeloma].
    Pruchniewski Ł; Kwiatek M; Gil L
    Pol Merkur Lekarski; 2018 Dec; 45(270):251-255. PubMed ID: 30693912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
    Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Kumar S; Munshi NC; Dispenzieri A; Kyle R; Merlini G; San Miguel J; Ludwig H; Hajek R; Jagannath S; Blade J; Lonial S; Dimopoulos MA; Einsele H; Barlogie B; Anderson KC; Gertz M; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Richardson PG; Niesvizky R; Rajkumar SV; Durie BG;
    Leukemia; 2009 Oct; 23(10):1904-12. PubMed ID: 19554029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group.
    Terpos E; Zamagni E; Lentzsch S; Drake MT; García-Sanz R; Abildgaard N; Ntanasis-Stathopoulos I; Schjesvold F; de la Rubia J; Kyriakou C; Hillengass J; Zweegman S; Cavo M; Moreau P; San-Miguel J; Dimopoulos MA; Munshi N; Durie BGM; Raje N;
    Lancet Oncol; 2021 Mar; 22(3):e119-e130. PubMed ID: 33545067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium.
    LeBlanc R; Bergstrom DJ; Côté J; Kotb R; Louzada ML; Sutherland HJ
    Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e41-e56. PubMed ID: 34456159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination in Multiple Myeloma: Review of Current Literature.
    Alemu A; Richards JO; Oaks MK; Thompson MA
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):495-502. PubMed ID: 27364264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.
    Teh BW; Slavin MA; Harrison SJ; Worth LJ
    Expert Rev Anti Infect Ther; 2015; 13(11):1325-36. PubMed ID: 26489539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.
    Terpos E; Sezer O; Croucher PI; García-Sanz R; Boccadoro M; San Miguel J; Ashcroft J; Bladé J; Cavo M; Delforge M; Dimopoulos MA; Facon T; Macro M; Waage A; Sonneveld P;
    Ann Oncol; 2009 Aug; 20(8):1303-17. PubMed ID: 19465418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
    Berenson JR; Hillner BE; Kyle RA; Anderson K; Lipton A; Yee GC; Biermann JS;
    J Clin Oncol; 2002 Sep; 20(17):3719-36. PubMed ID: 12202673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
    Lapietra G; Serrao A; Fazio F; Petrucci MT; Chistolini A
    J Thromb Thrombolysis; 2021 Aug; 52(2):584-589. PubMed ID: 33417149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.
    Bertolotti P; Bilotti E; Colson K; Curran K; Doss D; Faiman B; Gavino M; Jenkins B; Lilleby K; Love G; Mangan PA; McCullagh E; Miceli T; Miller K; Rogers K; Rome S; Sandifer S; Smith LC; Tariman JD; Westphal J
    Clin J Oncol Nurs; 2008 Jun; 12(3 Suppl):9-12. PubMed ID: 18490252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
    Nucci M; Anaissie E
    Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.